Pharmacokinetics of eleclazine, a highly selective inhibitor of cardiac late NA1 current: Evaluation of single and multiple-dose pk, and food effect, in healthy volunteers

Authors
Category Primary study
ConferenceClinical Pharmacology and Therapeutics
Year 2017
This article has no abstract
Epistemonikos ID: a07fe0073b8c9ab538bbb661e3a6c0e57284078c
First added on: Apr 29, 2026